Deroy & Devereaux Private Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $215K | Hold |
8,925
| – | – | 0.01% | 168 |
|
|
2026
Q1 | $251K | Sell |
8,925
-750
| -8% | -$20K | 0.01% | 156 |
|
|
2025
Q4 | $241K | Hold |
9,675
| – | – | 0.01% | 161 |
|
|
2025
Q3 | $247K | Buy |
9,675
+1,300
| +16% | +$32.1K | 0.01% | 155 |
|
|
2025
Q2 | $203K | Hold |
8,375
| – | – | 0.01% | 165 |
|
|
2025
Q1 | $212K | Buy |
8,375
+750
| +10% | +$19.6K | 0.01% | 162 |
|
|
2024
Q4 | $202K | Sell |
7,625
-1,982
| -21% | -$53.8K | 0.01% | 169 |
|
|
2024
Q3 | $278K | Hold |
9,607
| – | – | 0.02% | 153 |
|
|
2024
Q2 | $269K | Hold |
9,607
| – | – | 0.02% | 152 |
|
|
2024
Q1 | $267K | Sell |
9,607
-1,669
| -15% | -$46.3K | 0.02% | 160 |
|
|
2023
Q4 | $325K | Sell |
11,276
-800
| -7% | -$24.2K | 0.02% | 152 |
|
|
2023
Q3 | $401K | Sell |
12,076
-150
| -1% | -$5.3K | 0.03% | 139 |
|
|
2023
Q2 | $448K | Sell |
12,226
-150
| -1% | -$5.84K | 0.03% | 137 |
|
|
2023
Q1 | $505K | Sell |
12,376
-10,900
| -47% | -$471K | 0.04% | 107 |
|
|
2022
Q4 | $1.19M | Sell |
23,276
-350
| -1% | -$16.8K | 0.09% | 92 |
|
|
2022
Q3 | $1.03M | Sell |
23,626
-250
| -1% | -$12.1K | 0.09% | 94 |
|
|
2022
Q2 | $1.25M | Buy |
23,876
+800
| +3% | +$40.8K | 0.1% | 92 |
|
|
2022
Q1 | $1.2M | Buy |
23,076
+21
| +0.1% | +$1.09K | 0.09% | 98 |
|
|
2021
Q4 | $1.36M | Buy |
23,055
+619
| +3% | +$30.7K | 0.1% | 96 |
|
|
2021
Q3 | $965K | Sell |
22,436
-100
| -0.4% | -$4.43K | 0.08% | 100 |
|
|
2021
Q2 | $883K | Sell |
22,536
-500
| -2% | -$19.4K | 0.07% | 102 |
|
|
2021
Q1 | $835K | Sell |
23,036
-600
| -3% | -$21.3K | 0.07% | 102 |
|
|
2020
Q4 | $870K | Sell |
23,636
-1,276
| -5% | -$46.8K | 0.08% | 100 |
|
|
2020
Q3 | $867K | Sell |
24,912
-791
| -3% | -$27.7K | 0.09% | 97 |
|
|
2020
Q2 | $797K | Buy |
25,703
+6,271
| +32% | +$213K | 0.09% | 96 |
|
|
2020
Q1 | $602K | Buy |
19,432
+2,846
| +17% | +$97K | 0.08% | 99 |
|
|
2019
Q4 | $617K | Hold |
16,586
| – | – | 0.05% | 97 |
|
|
2019
Q3 | $565K | Buy |
16,586
+169
| +1% | +$6.14K | 0.06% | 100 |
|
|
2019
Q2 | $675K | Sell |
16,417
-791
| -5% | -$31.4K | 0.07% | 93 |
|
|
2019
Q1 | $693K | Sell |
17,208
-474
| -3% | -$19K | 0.07% | 97 |
|
|
2018
Q4 | $732K | Hold |
17,682
| – | – | 0.08% | 97 |
|
|
2018
Q3 | $739K | Sell |
17,682
-1,713
| -9% | -$65.9K | 0.07% | 102 |
|
|
2018
Q2 | $668K | Sell |
19,395
-1,064
| -5% | -$36.4K | 0.07% | 107 |
|
|
2018
Q1 | $689K | Sell |
20,459
-2,098
| -9% | -$72.1K | 0.07% | 107 |
|
|
2017
Q4 | $775K | Buy |
22,557
+116
| +0.5% | +$3.96K | 0.08% | 100 |
|
|
2017
Q3 | $760K | Sell |
22,441
-1,054
| -4% | -$33.9K | 0.09% | 98 |
|
|
2017
Q2 | $749K | Sell |
23,495
-8,988
| -28% | -$283K | 0.09% | 98 |
|
|
2017
Q1 | $1.05M | Sell |
32,483
-316
| -1% | -$9.96K | 0.12% | 91 |
|
|
2016
Q4 | $1.01M | Buy |
32,799
+11,067
| +51% | +$338K | 0.12% | 91 |
|
|
2016
Q3 | $698K | Buy |
21,732
+790
| +4% | +$26.4K | 0.09% | 98 |
|
|
2016
Q2 | $700K | Sell |
20,942
-9,616
| -31% | -$307K | 0.09% | 103 |
|
|
2016
Q1 | $859K | Sell |
30,558
-10,975
| -26% | -$313K | 0.12% | 92 |
|
|
2015
Q4 | $1.27M | Buy |
41,533
+21,463
| +107% | +$675K | 0.18% | 78 |
|
|
2015
Q3 | $598K | Sell |
20,070
-450
| -2% | -$14.4K | 0.09% | 104 |
|
|
2015
Q2 | $653K | Hold |
20,520
| – | – | 0.08% | 104 |
|
|
2015
Q1 | $677K | Sell |
20,520
-1,344
| -6% | -$42.7K | 0.08% | 100 |
|
|
2014
Q4 | $646K | Buy |
21,864
+3,979
| +22% | +$114K | 0.08% | 106 |
|
|
2014
Q3 | $502K | Buy |
17,885
+737
| +4% | +$20.7K | 0.08% | 103 |
|
|
2014
Q2 | $483K | Buy |
17,148
+9,223
| +116% | +$263K | 0.07% | 112 |
|
|
2014
Q1 | $242K | Sell |
7,925
-791
| -9% | -$23.6K | 0.04% | 151 |
|
|
2013
Q4 | $253K | Sell |
8,716
-790
| -8% | -$23K | 0.04% | 157 |
|
|
2013
Q3 | $259K | Sell |
9,506
-527
| -5% | -$14.3K | 0.05% | 131 |
|
|
2013
Q2 | $267K | Buy |
+10,033
| New | +$277K | 0.05% | 129 |
|
Other funds holding PFE
Deroy & Devereaux Private Investment Counsel's PFE Position: Q2 2026 in Review
Deroy & Devereaux Private Investment Counsel held its Pfizer (PFE) position steady in Q2 2026 at 8,925 shares worth $215K. The position accounts for 0.01% of the portfolio, ranked #168.
Deroy & Devereaux Private Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.36M in Q4 2021. 1,819 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Deroy & Devereaux Private Investment Counsel held 8,925 shares of Pfizer worth $215K as of Q2 2026.
- Deroy & Devereaux Private Investment Counsel left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.01% of Deroy & Devereaux Private Investment Counsel's portfolio in Q2 2026, its #168 holding.
- Deroy & Devereaux Private Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Deroy & Devereaux Private Investment Counsel's Pfizer position peaked at $1.36M in Q4 2021.
- 1,819 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.